Xianruida Medical-B (06669) issued an announcement. On March 20, 2024, the Group received China's national pharmaceuticals...
Zhitong Finance App News, Xianruida Medical-B (06669) issued an announcement. On March 20, 2024, the Group received registration approval from the China National Drug Administration for coronary hypertension balloon dilatation catheter wings. Pterygium is suitable for dilating coronary artery stenosis or coronary artery bypass vascular stenosis to improve myocardial perfusion. The company will launch marketing activities in the Chinese market in due course.